IPAH — Interpharm Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Interpharm Holdings, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2003 June 30th	2004 June 30th	2005 June 30th	2006 June 30th	2007 June 30th
Period Length:	6 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	15	41.1	39.9	63.4	75.6
Cost of Revenue
Gross Profit	2.74	9.79	9.07	17.4	21.7
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	13.7	36	40	68.1	86.3
Operating Profit	1.24	5.06	-0.095	-4.77	-10.7
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1.12	5.11	-0.222	-5.49	-13.9
Provision for Income Taxes
Net Income After Taxes	0.723	3.12	-0.149	-3.79	-14.1
Net Income Before Extraordinary Items
Net Income	0.723	3.12	-0.149	-3.79	-14.1
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	0.71	2.96	-0.315	-5.52	-16.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.017	0.043	-0.012	-0.151	-0.257
Dividends per Share